P
PROCEPT BioRobotics Corporation
PRCT · NASDAQ · Healthcare · 1.2B
Closing price
$18.40
+2.79% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.8×
Enterprise value / EBITDAEV/EBITDA
-9.5×
Free cash flow yieldFCF yield
-5.7%
Return on equityROE
-26.1%
Operating margin
-33.7%
Net debt / EBITDAbalance-sheet strength
2.4×
Interest coverage
-29.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.